Active Ingredient(s):Tenofovir Alafenamide FDA Approved: * November 10, 2016 Pharm Company: *GILEAD SCIENCES INC Category:Hepatitis
Tenofovir alafenamide, sold under the brand name Vemlidy, is a hepatitis B virus (HBV) nucleotide reverse transcriptase inhibitor medication for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease. It is taken by mouth.
Tenofovir alafenamide is a prodrug of tenofovir. It was developed by Gilead Sciences based on the protide technology of Chris McGuigan for use in the treatment of HIV/AIDS and chronic hepatit...
* May have multiple approval dates, manufacturers, or labelers.